Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

Amneal Releases Inaugural Corporate Responsibility Report Highlighting Impact as a Socially Responsible Company.

Document Cited in Related
Vincent

ENPNewswire-November 3, 2021--Amneal Releases Inaugural Corporate Responsibility Report Highlighting Impact as a Socially Responsible Company

(C)2021 ENPublishing - http://www.enpublishing.co.uk

Release date- 02112021 - BRIDGEWATER, N.J. - Amneal Pharmaceuticals, Inc. (NYSE: AMRX) ('Amneal' or the 'Company') announced the release of its inaugural Corporate Responsibility Report with primarily 2020 data and select 2021 highlights. This initial report provides stakeholders with details around the Company's commitment to good environmental, social and governance (ESG) practices that are strategic, impactful, and embedded into the Company's culture. The report highlights five key areas of impact relating to the Company's people, products, governance, planet and community, and includes a deeper look at Amneal's role in the fight against COVID-19.

'Since our founding in 2002, we have maintained a deep commitment to the core principles of ESG, and they are integrated throughout our Amneal 2.0 strategy. As we look out over the long-term, we believe all aspects of our company, particularly our people and products, have a profound opportunity to provide a meaningful and lasting impact for our stakeholders and the world,' said Chirag and Chintu Patel, Co-Chief Executive Officers.

By deepening its commitment to ESG practices, Amneal is focused on what matters most: responsibly helping make healthy possible through access to high-quality, accessible medications. The Company is driving that vision in the following ways: Strengthening the talent, diversity and capabilities of its employee family and Board of Directors...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT